The worldwide sales of starter cultures, which were previously estimated to be worth around US$ 1,123.1 million in 2022, are now expected to boost up. Currently, in the year 2023, the global starter cultures market value is figured out to be around US$ 1,191.6 million. Further, it is expected to develop with a higher average CAGR …
Author Archives: Editor AN
Increasing Incidence of Whim Syndrome to Propel the Growth of Market at 6% CAGR through 2033: FMI Study
The global Whim Syndrome market is currently in its infancy, but it is expected to grow significantly in the coming years. The increasing prevalence of Whim Syndrome, coupled with the growing demand for effective treatment options, is driving the growth of this market. According to a new market research report published by Future Market Insights, …
Growing Significance of Proactive Concept to Improve Patient Care Surging the Demand for Value-based Healthcare Services: Industry Predicted to Rise at 21.1% CAGR
The value-based healthcare services market is predicted to grow at a CAGR of 21.1% over the forecast period, according to FMI’s analysis. The industry’s value is anticipated to increase from US$ 3 Bn in 2023 to US$ 20.5 Bn by 2033 end. The market for value-based healthcare services market is being driven by rising healthcare …
Malaria Treatment Market to nearly reach US$ 3 Billion by 2033; expected to surge at a 5% CAGR | FMI Report
In 2023, the market for Malaria Treatment is projected to be valued US$ 1.80 billion, up from US$ 1.72 Billion in fiscal year 2022. The market is anticipated to increase at a 5% CAGR from 2023 to 2033, reaching US$ 2.93 billion by the end of that year. According to the Globe Intellectual Property Organization …
Veterinary Rehabilitation Services Market Value to touch US$ 2.1 Billion by 2033; Companion Animals to account for 70% of all Facility Uses | FMI
The global veterinary rehabilitation services market size is valued at US$ 792.5 Million in 2022 and it is anticipated to achieve a market valuation of US$ 882 Million in 2023. It is expected to reach a market valuation of US$ 2.1 Billion by the end of the forecast period while exhibiting a CAGR of 9.06%. …
Rising Frequency of Chronic Diseases to Drive the Market for Arterial Cannula | FMI Study
A recently published study by FMI expects the global arterial cannula market to augment at a 6.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 40 Billion is expected for the market. The rising frequency of chronic diseases necessitating cardiopulmonary bypass surgery (CABG), dialysis, and Extracorporeal …
One in Five People in the World Suffers from the Horrendous Condition of Chronic Pain Size of Chronic Pain Market to Puff up US$ 142.53 Bn by 2033
The chronic pain market is anticipated to grow from US$ 73.14 Bn in 2023 to US$ 142.53 Bn by 2033, rising at a CAGR of 6.9% during the forecast period. Globally, there were more than 187 Mn cases of chronic pain in 2020, and from 2023 to 2033, it is predicted that this number would increase dramatically. An ageing population, an …
Growing Incidence of Postoperative Pain and Emergence of Innovative Treatment Therapies to Drive Growth: Postoperative Pain Market to Surpass US$ 63 Billion By 2033
The global postoperative pain market is expected to be valued at US$ 38.43 Bn in 2023, surpassing US$ 63.8 Bn by 2033. The market is likely projected to rise at a CAGR of 5.2% during the forecast period. One of the key elements anticipated to support market expansion over the forecast period is the rising …
Nipah Virus (Niv) Infection Testing Market to Register 5.2% CAGR from 2023 to 2033 | FMI Study
During the forecast period 2023 to 2033, the Nipah virus (NiV) infection testing market is expected to grow at a value of 5.2% CAGR, according to Future Market Insights. By the year 2033, the global market for Nipah virus (NiV) infection testing is expected to rise up to a market valuation of US$ 3.277.49 million. …
Rituximab to account for 40% of all Intraocular Lymphoma Treatments; Global Market Worth to surpass US$ 1 Billion by 2023-end | FMI Report
The global market for intraocular lymphoma treatment is expected to be worth US$ 1.2 billion by the year of 2023. The market, which is estimated to be worth US$ 2.3 billion by 2033, will grow at a 6.7% CAGR, according to the market intelligence firm, Future Market Insights. Intraocular lymphomas are uncommon cancers that present …